Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 21 2016

Full Issue

After 30 Years Of Stagnation, Big Pharma Jumps Back In Antibiotics Game. But Is It Too Late?

Developing antibiotics isn't profitable. But with the looming threat of resistance sparking concerns globally, pharmaceutical companies may be starting to pay attention.

Bloomberg: Inside The 10-Year, $1 Billion Battle For The Next Critical Antibiotic

In a cramped lab in rural Pennsylvania, surrounded by technicians in obligatory white lab coats and fume hoods leaking an occasional acrid smell, Neil Pearson holds up a plastic model of a chemical compound that resembles a spidery piece of Lego. Pearson, a 54-year-old chemist and senior fellow at British pharmaceutical giant GlaxoSmithkline Plc, explains how he spent more than a decade tinkering with chemical compounds before engineering a molecule that may yield the industry’s first truly new antibiotic in 30 years to fight the rise of superbugs that risk killing an extra 10 million people every year by 2050. (Baker, 9/20)

Politico Pro: Antibiotic Resistance Takes The World Stage

The United Nations will hold a high-level meeting Wednesday on antibiotic resistance — placing the largely invisible issue on par with HIV and Ebola as a burgeoning global health crisis. Some predict it will be a breakthrough moment for a growing problem that already kills 70,000 people a year, bringing attention to it in a way that could push the FDA and Congress to take the needed additional steps to end political and regulatory gridlock. Though influence from both the powerful agriculture and drug industries have weakened past efforts, more and more industry groups are at least starting to acknowledge there’s a problem. (Kullgren, 9/21)

The Washington Post: ‘Superbug’ MRSA May Be Spreading Through Tainted Poultry

A new form of a dangerous "superbug" may be spreading to humans through contaminated poultry that people handle or eat, according to a study published Wednesday. Researchers focused on a newly identified strain of the bacterium known as MRSA, or methicillin-resistant Staphylococcus aureus, that they found in people in Denmark. Although most individuals who become infected with MRSA don't get it from food, the study suggests that this poultry-associated strain may be more easily transmitted from food to people. (Sun, 9/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, July 23
  • Wednesday, July 22
  • Tuesday, July 21
  • Monday, July 20
  • Friday, July 17
  • Thursday, July 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF